Kuros Biosciences
-
Biologics
Kuros Biosciences Receives European Clearance for MagnetOs Putty and Prepares for Commercial Roll-Out in the U.S. and Europe
SCHLIEREN (ZURICH), Switzerland, May 02, 2018 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX:KURN) announced today that it has received the CE…
Read More » -
Financial
Kuros Biosciences Reports Full-Year 2017 Results
Financial highlights CHF 17.0 million cash at year-end CHF 16.9 million equity raise in June 2017 Standby equity facility established…
Read More » -
Hospitals
Kuros Biosciences obtains European patent covering osteoinductive materials
Schlieren (Zurich), Switzerland, March 12, 2018 Kuros announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the…
Read More » -
Biologics
Kuros Biosciences Announces Management Succession
Schlieren (Zurich), Switzerland, December 14, 2017 Kuros announced today the appointment of Michael Grau as Chief Financial Officer (CFO) effective…
Read More » -
Biologics
Kuros Biosciences’ Chief Medical Officer to Retire
Schlieren (Zurich), Switzerland, November 28, 2017 Kuros announced today that its Chief Medical Officer, Dr. Virginia Jamieson, has reached retirement…
Read More » -
Financial
Kuros Biosciences May Secure Equity Financing of up to CHF 30 million
Schlieren (Zurich), Switzerland, November 22, 2017 Kuros (SIX: KURN) announced today it has entered into a Standby Equity Distribution Agreement…
Read More » -
Financial
Kuros Biosciences Reports Financial Results for First Half-Year of 2017
26 Sep 17 Kuros, an orthobiologic company with several commercial-stage products, today announced the financial figures for the first six…
Read More » -
Biologics
Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe
Schlieren (Zurich), Switzerland, August 28, 2017 – Kuros Biosciences announced today that it has received 510(k) clearance from the US…
Read More » -
Hospitals
Kuros Biosciences submits MagnetOs Putty for US FDA Clearance
06 Jun 17 Kuros (SIX:KURN) today announced it has filed the submission package for MagnetOs Putty seeking 510(k) clearance from…
Read More » -
Biologics
General Meeting of Kuros Biosciences approves all resolutions
23 May 17 Kuros Biosciences announced that yesterday’s General Meeting approved all resolutions proposed by the Board of Directors with…
Read More »